Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intuitive Surgical Inc buy geldnutzer

Intuitive Surgical Inc
Start price
€512.10
29.12.24 / 60%
Target price
€533.00
29.12.25
Performance (%)
-4.32%
End price
€490.00
30.12.25
Summary
This prediction ended on 30.12.25 with a price of €490.00. With a performance of -4.32%, the BUY prediction by geldnutzer finished with a loss. geldnutzer has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Intuitive Surgical Inc 5.079% 5.079% -5.726%
iShares Core DAX® 3.002% 3.742% 24.169%
iShares Nasdaq 100 2.966% 1.308% 9.141%
iShares Nikkei 225® 5.606% 4.472% 21.237%
iShares S&P 500 2.312% 1.880% 6.333%

According to geldnutzer what are the pros and cons of Intuitive Surgical Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
Cons
Growths slower than the competition
Sustainability is little important
Little known brand
Low dividend yield expected

Comments by geldnutzer for this prediction

In the thread Intuitive Surgical Inc diskutieren
Prediction Buy
Perf. (%) -4.32%
Target price 553.000
Change
Ends at 29.12.25

Buy mit Kursziel 553,0

geldnutzer 
0
Report Share
29.12.24
Prediction Buy
Perf. (%) -4.32%
Target price 593.000
Change
Ends at 29.12.25

Kursziel geändert auf 593,0

geldnutzer 
0
Report Share
21.01.25
Prediction Buy
Perf. (%) -4.32%
Target price 493.000
Change
Ends at 29.12.25

Kursziel geändert auf 493,0

geldnutzer 
0
Report Share
28.06.25
Prediction Buy
Perf. (%) -4.32%
Target price 433.000
Change
Ends at 29.12.25

Kursziel geändert auf 433,0

geldnutzer 
0
Report Share
05.08.25
Prediction Buy
Perf. (%) -4.32%
Target price 533.000
Change
Ends at 29.12.25

Kursziel geändert auf 533,0

geldnutzer 
0
Report Share
08.12.25
In the thread Trading Intuitive Surgical Inc
Prediction Buy
Perf. (%) -4.32%
Target price 533.000
Change
Ends at 29.12.25

Die von geldnutzer gewählte maximale Laufzeit wurde überschritten

geldnutzer 
0
Report Share
30.12.25

Stopped prediction by geldnutzer for Intuitive Surgical Inc

buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€246.90
30.01.22
€270.00
30.01.23
-9.98%
31.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
30.01.22 60%
sell
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€225.60
24.01.22
€210.00
24.01.23
9.44%
30.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
24.01.22 60%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€304.50
13.12.21
€330.00
13.12.22
-25.91%
24.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
13.12.21 60%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€56.83
27.02.16
€64.94
20.04.16
15.27%
20.04.16

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
15.08.19 50%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€50.31
09.02.16
€61.94
23.02.16
9.07%
23.02.16

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
15.08.19 50%